News Release VacciXcell

News


 

Catching the Tide: How VacciXcell's TideMotion Bioreactor is Innovating Bioprocessing

 

Nov 08, 2016

 

Biopharmaceutical companies and industries around the world use cell culture as a means of producing their bio products. Whether the company is producing vaccines, monoclonal anti-bodies, proteins, biosimilars or stem cells, using some type of bioreactor is the widely accepted and most efficient method of doing it.

Bioreactors range from the most basic types, such as egg bioreactors, to scalable types such as stirred tanks and packed beds. With so many types of bioreactors in the market, the challenge is choosing the best one for the desired application from the get go.

If choosing the most suitable bioreactor is not challenging enough, there are numerous other factors to also consider such as scaling up and parameter optimization to name a few. It is due to the ever changing environment during cell culture that industries tend to update and upgrade the technology to better fit their requirements.

VacciXcell's TideMotion bioreactor is currently one of the innovations that is available in the market for high density adherent cell culture. VacciXcell's TideMotion bioreactor has some major advantage vs traditional systems such as packed bed bioreactors and Stirred Tank w/microcarrier systems.

VacciXcell TideMotion Bioreactors

To know more about VacciXcell's TideMotion in comparison to packed bed bioreactors (click here)

To know more about VacciXcell's TideMotion in comparison to stirred tank w/ microcarriers (click here)

Due to being one of the most innovative technology currently available in the market, VacciXcell's TideMotion technology has attracted attention from the bioprocessing industry. Presented here are some of the most recent customers that VacciXcell has been working with.

We at VacciXcell value the confidentiality of our customer's information and as such some categories are filled in as "confidential".

Companies that recently bought VacciXcell's TideMotion Bioreactor:

Country

Pakistan

Company

Nuclear Institute for Agriculture and Biology

Description

A national institute under the Pakistan Atomic Energy Commission

Desired Product

Veterinary vaccine using PPR virus

Cell Line

Vero cell

Reason for switching

Technology upgrade

Previous Technology:

New Technology:

 

Country

Spain

Company

Confidential

Desired Product

Veterinary Diagnostic Assays

Cell Line

Confidential

Reason for switching

Desire for higher yield

Previous Technology:

New Technology:

 

Companies currently trying out VacciXcell's TideMotion Bioreactor:

Country

Morocco

Company

M.C.I Sante animale

Desired Product

Veterinary vaccine using secreted virus

Cell Line

Vero cell

Reason for switching

Previous technology did not work as desired

Previous Technology:

New Technology:

 

Country

Indonesia

Company

Confidential

Desired Product

Human Vaccine (Influenza)

Cell Line

MDCK

Reason for switching

To increase production

Previous Technology:

New Technology:

As the race for medical advancement continues, the one with the best and most efficient technology is sure to come out ahead. Do not get left behind and catch the Tide!

For inquiries or trial requests, contact us at mail@vaccixcell.com.